Dobrin Vassilev

Showing 1-7 of 7 articles

Coronary interventions

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials

Gil R, Bil J, Kern A, Ingio Garcia L, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A

March 20, 2020 | 10.4244/EIJ-D-18-00172

Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study

Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00189

Coronary interventions

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R, Bil J, Grundeken M.J, Kern A, Iñigo Garcia L, Vassilev D, Pawłowski T, Formuszewicz R, Dobrzycki S, Wykrzykowska J, Serruys P

December 9, 2016 | 10.4244/EIJY15M11_11

Coronary interventions

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

Gil R, Bil J, Grundeken M.J, Iñigo Garcia L, Vassilev D, Kern A, Pawłowski T, Wykrzykowska J, Serruys P

November 20, 2016 | 10.4244/EIJY15M10_05

Coronary interventions

The BiOSS stent

Gil R, Bil J, Vassilev D

May 19, 2015 | 10.4244/EIJV11SVA37

Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population

Gil R, Vassilev D, Michalek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A

July 27, 2012 | 10.4244/EIJV8I3A50

Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model

Vassilev D, Gil R, Milewski K

September 30, 2011 | 10.4244/EIJV7I5A98

1

Latest news

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Valvular disease